Tyrone Lam is Chief Business Development Officer at GATC Health, a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. GATC Health’s Operon™ AI platform and its Derisq™ AI report are trusted by biopharma, researchers, investment firms, and the world’s largest insurance marketplace to assess and predict drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. Before joining GATC Health in 2021, Lam built and scaled companies at the intersection of analytics, digital platforms, and life sciences. He co-founded First Americans Wellness, a healthcare organization focused on improving health outcomes for Native American communities through collaborative partnerships with tribal governments, and previously founded OneRecovery, a pioneering, award-winning behavior-change platforms that used member engagement, game mechanics, and evidence-based clinical principles to improve health outcomes and lower the cost of chronic care. Lam’s experience includes leadership roles in predictive analytics and digital health, including Predilytics, a machine learning platform acquired by Welltok, where he helped advance data-driven approaches to population health and outcomes optimization. Across his career, he has led business development, marketing, and cross-sector partnerships bridging technology, healthcare, and policy, and he previously served as President and Chief Operating Officer of NTN Buzztime, a publicly traded entertainment company, where he led operations and market expansion during a period of rapid growth and industry firsts in early interactive media. Lam holds a Bachelor of Arts in Political Science and Government from Virginia Tech and regularly speaks on the commercialization of technology in life sciences, the future of predictive drug development, and the evolving role of AI in regulatory and investment decision-making.